Related Experiment Video
Updated: Dec 9, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis
Qiqing Sun1,2,3,4, Zeng Ye1,2,3,4, Yi Qin1,2,3,4
1Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, 200032, Shanghai, China.
Abstract:
Evidence suggests that tripartite motif-containing 2 (TRIM2) is associated with carcinogenic effects in several malignancies. However, the expression patterns and roles of TRIM2 in pancreatic cancer are rarely studied. Our study demonstrated that TRIM2 was expressed in a high percentage of pancreatic tumors. High TRIM2 expression was negatively correlated with the outcome of pancreatic cancer. TRIM2 silencing significantly inhibited the proliferation, migration, invasion, and in vivo tumorigenicity of pancreatic cancer cells. Regarding the mechanism involved, TRIM2 activated ROS-related E2-related factor 2 (NRF2)/antioxidant response element (ARE) signaling and the integrin/focal adhesion kinase (FAK) pathway. Treatment of pancreatic cancer cells with the antioxidant N-acetyl-L-cysteine decreased ROS activity and expression level of NRF2 and ITGB7. Increased translocation of NRF2 protein into nucleus further rescued the inhibited ITGB7 transcription. Moreover, NRF2 bound to the potential ARE on the promoter region and enhanced the transcriptional activity of ITGB7, indicating the bridging effect of NRF2 between the two signaling pathways. In summary, our study provides evidence that upregulated TRIM2 in pancreatic cancer predicts short survival for pancreatic cancer patients. TRIM2 accelerates pancreatic cancer progression via the ROS-related NRF2/ITGB7/FAK axis.
Insights
High tripartite motif-containing 2 (TRIM2) expression in pancreatic cancer predicts poor survival. TRIM2 promotes tumor growth and spread by activating the ROS-related NRF2/ITGB7/FAK pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Tripartite motif-containing 2 (TRIM2) is implicated in various cancers.
- Its role in pancreatic cancer remains largely unexplored.
- Understanding TRIM2's function is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the expression patterns and functional significance of TRIM2 in pancreatic cancer.
- To elucidate the underlying molecular mechanisms by which TRIM2 influences pancreatic cancer progression.
Main Methods:
- Analysis of TRIM2 expression in pancreatic tumor samples.
- In vitro and in vivo functional assays following TRIM2 silencing.
- Investigation of TRIM2's impact on ROS-related NRF2/ARE and integrin/FAK signaling pathways.
Main Results:
- TRIM2 is highly expressed in pancreatic tumors and correlates with poor patient outcomes.
- TRIM2 silencing inhibits pancreatic cancer cell proliferation, migration, invasion, and tumorigenicity.
- TRIM2 activates the ROS-related NRF2/ITGB7/FAK axis, promoting cancer progression.
Conclusions:
- Upregulated TRIM2 is a prognostic marker for pancreatic cancer patients.
- TRIM2 drives pancreatic cancer progression through the ROS-related NRF2/ITGB7/FAK signaling axis.
- Targeting TRIM2 may offer a novel therapeutic strategy for pancreatic cancer.
More Related Videos
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...